시장 영업 전: 1.30

넥타테라퓨틱스 (NKTR)

Nektar Therapeutics 주식(NKTR)의 최신 뉴스

넥타테라퓨틱스 (NKTR)

Nektar Therapeutics 주식(NKTR)의 최신 뉴스

BTIG upgrades Nektar stock, sees upside on Rezpeg potential - Investing.com India

Nektar rises 11% as BTIG initiates buy rating on autoimmune disorders asset - Seeking Alpha

BTIG Research Reiterates "Buy" Rating for Nektar Therapeutics (NASDAQ:NKTR) - MarketBeat

BTIG upgrades Nektar stock, sees upside on Rezpeg potential - Investing.com

Renaissance Technologies LLC Sells 1,306,848 Shares of Nektar Therapeutics (NASDAQ:NKTR) - MarketBeat

836,000 Shares in Nektar Therapeutics (NASDAQ:NKTR) Acquired by Armistice Capital LLC - MarketBeat

Nektar Therapeutics Announces Multiple Presentations for Rezpegaldesleukin at EADV 2024 - cnhinews.com

Samlyn Capital LLC Makes New $11.73 Million Investment in Nektar Therapeutics (NASDAQ:NKTR) - MarketBeat

Market Momentum Report: Nkarta Inc (NKTX)’s Negative Close at 5.21 - The Dwinnex

Raymond James Upgrades Nkarta Inc (NKTX) to a Strong buy from an Outperform - Knox Daily

Taking a Closer Look At Nerdy Inc (NRDY) Following Its Recent Trade - Knox Daily

ARS Pharmaceuticals Announces U.S. Availability of neffy® - GlobeNewswire

Federated Hermes Inc. Boosts Stock Position in Nkarta, Inc. (NASDAQ:NKTX) - Defense World

Bank of New York Mellon Corp Grows Stock Position in Nektar Therapeutics (NASDAQ:NKTR) - MarketBeat

Neon City Festival announces headliners at Fremont - Fox 5 Las Vegas

Meta platforms' chief legal officer sells shares worth over $486k - Investing.com India

Primecap Management Co. CA Has $7.47 Million Stock Holdings in Nektar Therapeutics (NASDAQ:NKTR) - MarketBeat

Neat further reduces London estate as co-founder departs business - Restaurant

Nektar Therapeutics (NASDAQ:NKTR) Shares Sold by Acadian Asset Management LLC - MarketBeat

Acadian Asset Management LLC Sells 2,684,469 Shares of Nektar Therapeutics (NASDAQ:NKTR) - Defense World

Candriam S.C.A. Takes $99,000 Position in Nektar Therapeutics (NASDAQ:NKTR) - Defense World

Nektar Management to Present at Upcoming Investor Conferences - Kilgore News Herald

Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Rating of “Hold” by Brokerages - Defense World

Monaco Asset Management SAM Sells 3,665,133 Shares of Nektar Therapeutics (NASDAQ:NKTR) - MarketBeat

What Makes Nektar (NKTR) a New Buy Stock - MSN

Nektar Therapeutics' (NASDAQ:NKTR) institutional investors lost 12% over the past week but have profited from longer-term gains - Simply Wall St

Nektar Management to Present at Upcoming Investor Conferences - StockTitan

Nektar Management to Present at Upcoming Investor Conferences - Yahoo Finance

Nektar Therapeutics (NKTR) Reports Q2 Loss, Tops Revenue Estimates - MSN

Nektar Can't Get Docs It Says Show Lilly As 'Thieves, Liars' - Law360

Nektar's (NKTR) Q2 Earnings Lag Estimates, Revenues Top - MSN

Nektar Therapeutics Reports Second Quarter 2024 Financial Results - Longview News-Journal

Nektar Therapeutics exec sells shares to cover tax By Investing.com - Investing.com Australia

Nektar Therapeutics CEO sells shares worth over $19,000 By Investing.com - Investing.com Australia

Nektar Therapeutics executive sells shares to cover tax By Investing.com - Investing.com Australia

Nektar Therapeutics CEO sells shares worth over $19,000 - Investing.com India

Howard W. Robin Sells 14,881 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock - MarketBeat

Nektar Therapeutics CEO sells shares worth over $19,000 - Investing.com

Nektar Therapeutics executive sells shares to cover tax - Investing.com

Nektar Therapeutics exec sells shares to cover tax - Investing.com

Nektar Therapeutics CEO sells shares worth over $19,000 By Investing.com - Investing.com Canada

Nektar Therapeutics executive sells shares to cover tax By Investing.com - Investing.com UK

Values First Advisors Inc. Makes New Investment in Nektar Therapeutics (NASDAQ:NKTR) - Defense World

Nektar Therapeutics (NASDAQ:NKTR) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Rating of “Hold” by Analysts - Defense World

Nektar Therapeutics (NASDAQ:NKTR) Share Price Crosses Above Two Hundred Day Moving Average of $1.18 - MarketBeat

Nektar Therapeutics (NASDAQ:NKTR) Shares Pass Above 200-Day Moving Average of $1.18 - Defense World

What Makes Nektar (NKTR) a New Buy Stock - Yahoo Canada Finance

What Makes Nektar (NKTR) a New Buy Stock - Yahoo Finance

Nektar Therapeutics (NKTR) Q2 2024 Earnings Call Transcript - Seeking Alpha

Nektar Therapeutics Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nektar's (NKTR) Q2 Earnings Lag Estimates, Revenues Top - Yahoo Finance

Nektar: Q2 Earnings Snapshot - CTPost

Nektar: Q2 Earnings Snapshot - Houston Chronicle

Nektar: Q2 Earnings Snapshot - San Antonio Express-News

Nektar: Q2 Earnings Snapshot - San Francisco Chronicle

Nektar Therapeutics (NKTR) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Nektar Therapeutics (NKTR) Misses Q2 EPS by 6c - StreetInsider.com

Nektar Therapeutics Q2 2024 Earnings: Revenue Surpasses Estimates at $23.5M, EPS Misses at -$0.25 - GuruFocus.com

Nektar: Q2 Earnings Snapshot - The Bakersfield Californian

Nektar Therapeutics Reports Second Quarter 2024 Financial Results - StockTitan

Q4 2024 EPS Estimates for Nektar Therapeutics Lifted by Analyst (NASDAQ:NKTR) - Defense World

Q4 2024 EPS Estimates for Nektar Therapeutics Lifted by Zacks Research (NASDAQ:NKTR) - MarketBeat

How does Nektar Therapeutics (NKTR) change from a tortoise to a hare? - SETE News

Nektar Therapeutics (NKTR) to Release Quarterly Earnings on Thursday - Defense World

Public Employees Retirement System of Ohio Sells 105,175 Shares of Nektar Therapeutics (NASDAQ:NKTR) - Defense World

Investing in Nektar Therapeutics (NKTR) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News

NKTR Stock Earnings: Nektar Therapeutics Meets EPS, Beats Revenue for Q1 2024 - MSN

Nektar Therapeutics (NKTR) to Release Quarterly Earnings on Thursday - MarketBeat

Russell Investments Group Ltd. Has $77,000 Stake in Nektar Therapeutics (NASDAQ:NKTR) - Defense World

NKTR과 유사한 종목